Form 8-K - Current report:
SEC Accession No. 0001437749-23-007054
Filing Date
2023-03-17
Accepted
2023-03-17 16:04:11
Documents
13
Period of Report
2023-03-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K clnn20230206_8k.htm   iXBRL 8-K 29971
  Complete submission text file 0001437749-23-007054.txt   183613

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA clnn-20230315.xsd EX-101.SCH 4129
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE clnn-20230315_def.xml EX-101.DEF 14031
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE clnn-20230315_lab.xml EX-101.LAB 18484
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clnn-20230315_pre.xml EX-101.PRE 14053
7 EXTRACTED XBRL INSTANCE DOCUMENT clnn20230206_8k_htm.xml XML 4669
Mailing Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121
Business Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121 801-676-9695
Clene Inc. (Filer) CIK: 0001822791 (see all company filings)

EIN.: 852828339 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39834 | Film No.: 23742493
SIC: 2834 Pharmaceutical Preparations